Skip to main content
. Author manuscript; available in PMC: 2023 Dec 12.
Published in final edited form as: J Affect Disord Rep. 2023 Jun 24;14:100615. doi: 10.1016/j.jadr.2023.100615

Fig. 1.

Fig. 1.

Consort diagram showing subject flow. Female subjects were screened and consented based on a history of early childhood sexual abuse and then divided into current PTSD and non-PTSD groups. Subsequent screening after consenting led to additional exclusions in the PTSD group and subjects who lost interest or were lost to followup in both groups. PTSD patients were then randomized to paroxetine or placebo and all subjects were scanned at baseline with personalized traumatic scripts and memory tasks. PTSD patients then underwent three months of double-blind treatment with paroxetine or placebo, during which time there were additional dropouts and patients lost to followup. Remaining patients were rescanned using the same protocol after three months.